Mark Wakefield

Division Chief and Program Director

University of Missouri Columbia School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mark Wakefield serves as the Division Chief and Program Director at the University of Missouri Columbia School of Medicine in the United States. His research primarily focuses on cancer, particularly in exploring tumor microenvironments, immunotherapy, and advanced treatment paradigms including precision medicine. Recent publications highlight his work on gastrointestinal cancers, osteosarcoma, and novel therapeutic approaches for melanoma and bladder cancer.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Katie Murray

University of Missouri Columbia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Wakefield

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Exploring the Tumor Microenvironment in Osteosarcoma: Driver of Resistance and Progression

Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact

Beyond Detection: Conventional and Emerging Biomarkers in Gastrointestinal Cancers

From Spice to Survival: The Emerging Role of Curcumin in Cancer Immunotherapy

Causes and Effects of Postoperative Sleep Disorders and Treatment Strategies for Preoperative, Intraoperative, and Postoperative Settings—A Narrative Review

Osteosarcoma: current insights and advances

A Consolidated Review of Contemporary Targeted and Immunotherapeutic Options for Melanoma

The Era of Precision Medicine: Advancing Treatment Paradigms for Small Cell Lung Cancer

Cytokine Therapy in Bladder Cancer: Mechanisms, Efficacy, and Future Prospects

From Bench to Bladder: The Rise in Immune Checkpoint Inhibition in the Treatment of Non-Muscle Invasive Bladder Cancer

Emerging molecular therapies in the treatment of bladder cancer

Photodynamic Therapy, Probiotics, Acetic Acid, and Essential Oil in the Treatment of Chronic Wounds Infected with Pseudomonas aeruginosa

Impact of COVID-19 on Male Fertility

Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment

<p>A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve?</p>

Disseminated nocardia infection in an old Male patient with nephrotic syndrome

Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE™ results of the MAGIC randomized clinical trial

Collaborators (1)

Katie Murray

Make your next move.